Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Hsiu-Ying Ku"'
Autor:
Chih‐Chieh Yen, Yi‐Hsin Yang, Hsiu‐Ying Ku, Huang‐Ming Hu, Su‐Shun Lo, Hung‐Chi Chang, Yee Chao, Jen‐Shi Chen, Hsiu‐Po Wang, Tsang‐En Wang, Li‐Yuan Bai, Ming‐Shiang Wu, Chia‐Jui Yen, Li‐Tzong Chen, Yan‐Shen Shan
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 16906-16917 (2023)
Abstract Background Gastrectomy remains the curative option in gastric cancer. However, the growing concern that preoperative waiting jeopardizes survival has not been fully addressed. The present population‐based cohort study aimed to clarify the
Externí odkaz:
https://doaj.org/article/afd010633a3f46fc98458e76aa241873
Autor:
Li-Hsin Chien, Tzu-Jui Tseng, Tzu-Yu Chen, Chung-Hsing Chen, Chia-Yu Chen, Hsin-Fang Jiang, Fang-Yu Tsai, Hsiu-Ying Ku, Shih Sheng Jiang, Chao A. Hsiung, Tsang-Wu Liu, I-Shou Chang
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract Because of the cancer incidence increase and population aging in Taiwan, we aimed to assess the cancer prevalence, to summarize the comorbidities of older patients with the five most common cancers (i.e., breast, colorectal, liver, lung, and
Externí odkaz:
https://doaj.org/article/683ec040c36e4156acb4f5bda90de552
Autor:
Chia-Chin Li, Chih-Yi Chen, Ying-Hsiang Chou, Chih-Jen Huang, Hsiu-Ying Ku, Ying-Chun Lin, Chun-Ru Chien
Publikováno v:
Discover Oncology, Vol 13, Iss 1, Pp 1-11 (2022)
Abstract Background The optimal radiotherapy dose for locally advanced esophageal squamous cell carcinoma in endemic areas treated with neoadjuvant concurrent chemoradiotherapy is unclear. Methods Eligible patients diagnosed between 2010 and 2019 wer
Externí odkaz:
https://doaj.org/article/dbd2ab9575124ed0a847e8179330580c
Autor:
Zhe-Rong Zheng, Hsiu-Ying Ku, Kun-Chieh Chen, Chun-Ju Chiang, Chih-Liang Wang, Chih-Yi Chen, Chun-Ming Tsai, Ming-Shyan Huang, Chong-Jen Yu, Jin-Shing Chen, Teh-Ying Chou, Wen-Chung Lee, Chun-Chieh Wang, Tsang-Wu Liu, Jiun-Yi Hsia, Gee-Chen Chang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionAnaplastic lymphoma kinase (ALK) fusion mutation is more common in younger and never-smoking lung cancer patients. The association of smoking and ALK-tyrosine kinase inhibitors (TKIs) on overall survival (OS) of treatment-naïve ALK-posit
Externí odkaz:
https://doaj.org/article/c3b9b5884b7e45a08b99a9fcc2d49146
Autor:
Ya-Yu Yang, Sheng-Chieh Lin, Jong-Ding Lay, Chun-Yu Cho, Te-Hsuan Jang, Hsiu-Ying Ku, Chih-Jung Yao, Shuang-En Chuang
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 19, p 14879 (2023)
About 80% of lung cancer patients are diagnosed with non–small cell lung cancer (NSCLC). EGFR mutation and overexpression are common in NSCLC, thus making EGFR signaling a key target for therapy. While EGFR kinase inhibitors (EGFR–TKIs) are widel
Externí odkaz:
https://doaj.org/article/b2190d3f225241f7b1468536fb899ca5
Autor:
Huang-Ming Hu, Hui-Jen Tsai, Hsiu-Ying Ku, Su-Shun Lo, Yan-Shen Shan, Hung-Chi Chang, Yee Chao, Jen-Shi Chen, Shu-Chen Chen, Chun-Ju Chiang, Anna Fen-Yau Li, Hsiu-Po Wang, Tsang-En Wang, Li-Yuan Bai, Ming-Shiang Wu, Li-Tzong Chen, Tsang-Wu Liu, Yi-Hsin Yang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Chemotherapy is generally considered as the main treatment for metastatic gastric adenocarcinoma. The role of gastrectomy for metastatic gastric cancer without obvious symptoms is controversial. The objective of this study is to investigate
Externí odkaz:
https://doaj.org/article/6d79e1ee763b4d4a95259e0871837120
Publikováno v:
Thoracic Cancer, Vol 12, Iss 14, Pp 2065-2071 (2021)
Abstract Background The optimal radiotherapy dose for locally advanced cervical esophageal squamous cell carcinoma (C‐ESqCC) treated with definitive concurrent chemoradiotherapy (dCCRT) is unclear. Here, we aimed to compare the survival of those tr
Externí odkaz:
https://doaj.org/article/9501bb2efc8247f58b64c8a78acb55e0
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background The role of radiotherapy for cT4bNanyM0 esophageal squamous cell carcinoma (ESqCC) is relatively unclear, with both chemotherapy (C/T) alone and definitive concurrent chemoradiotherapy (dCCRT) being treatment options in the curren
Externí odkaz:
https://doaj.org/article/d7ac044192e742db8921c974a1054b74
Autor:
Kwong-Ming Kee, Chien-Hung Chen, Jui-Ting Hu, Yi-Hsiang Huang, Tsang-En Wang, Gar-Yang Chau, Kuo-Hsin Chen, Yao-Li Chen, Chih-Che Lin, Chien-Fu Hung, Shiu-Feng Huang, Tsang-Wu Liu, Hsiu-Ying Ku, Bing-Shen Huang, Yi-Pin Wang, Hui-Ping Tseng, Chun-Ju Chiang, Sheng-Nan Lu
Publikováno v:
Viruses, Vol 15, Iss 1, p 126 (2022)
Hepatocellular carcinoma (HCC) is a major cause of cancer death in Taiwan, and in the past 30–40 years, Taiwan has been committed to its prevention and treatment. We aimed to investigate the secular trends of characteristics and the survival of HCC
Externí odkaz:
https://doaj.org/article/680dc7a220944016bfb1d3e8762b29cd
Autor:
Nai-Yueh Ko, Yuan-Ting C Lo, Zu-Yi Sia, Ya-Chi Lu, Jhih-Yuan Wei, Ming-Jhou Cai, Hsiu-Ying Ku, Senyeong Kao, Hsien-Liang Su, Junn-Liang Chang, Han-Bin Huang
Publikováno v:
Journal of Medical Sciences, Vol 38, Iss 6, Pp 258-268 (2018)
Background: Phthalate esters (PAEs), which may have potential adverse health effects, are widely used in industrial and consumer products. The public raised concerns of exposure to PAEs after di-2-ethylhexyl PAE (DEHP) had been illegally used in food
Externí odkaz:
https://doaj.org/article/c3d4bcde55514f4c95de23b925c9e5ac